The global urinary incontinence treatment devices market size was estimated to be USD 3.23 billion in 2023 and is expected to reach USD 7.36 billion by 2034 with a CAGR of 7.76% during the forecast period 2024-2034. The rising prevalence of urinary incontinence, growing aging population, advancements in treatment technologies, increasing healthcare awareness and focus on quality of life, technological advancements in device manufacturing, growing focus on home-based care, increasing reimbursement coverage, and rising demand for minimally invasive procedures will drive market growth.
Urinary incontinence is a prevalent ailment that affects millions of individuals worldwide, with one in every four women and one in every ten men experiencing it at some time in their lives. The prevalence of urine incontinence rises with age, with more than half of persons over 65 suffering from the disorder. Obesity, neurological problems, and childbirth can all play a role in the development of urine incontinence. For instance, Medtronic plc received FDA clearance for its InterStimTM S9 system, a neurostimulation device for treating overactive bladder syndrome and urine urgency incontinence, in December 2023.
By product, the urethral slings segment accounted for the highest revenue-grossing segment in the global urinary incontinence treatment devices market in 2023 owing to the increasing prevalence of stress urinary incontinence and the effectiveness of urethral slings in providing long-term relief, driving heightened demand for this specific treatment option among healthcare providers and patients alike. For instance, Boston Scientific Corporation announced the successful enrollment of the first patients in a clinical study assessing their IntellisensTM System, a smart drainage catheter with real-time fluid monitoring, in November 2023. Additionally, the electrical stimulation devices segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising adoption of non-invasive and technologically advanced solutions for urinary incontinence management, increased awareness about the effectiveness of electrical stimulation in strengthening pelvic floor muscles, and the growing preference for conservative treatment options.
By incontinence type, the stress urinary incontinence segment accounted for the highest revenue-grossing segment in the global urinary incontinence treatment devices market in 2023 owing to the growing prevalence of stress urinary incontinence, particularly among women, increased awareness and diagnosis rates, and the effectiveness of specialized treatment devices tailored to address the specific needs of individuals with stress urinary incontinence. For instance, Coloplast A/S announced a strategic agreement with Oxford University Hospitals in December 2023 to develop and test novel technologies for the management of urinary incontinence. Additionally, the mixed incontinence segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing recognition of the complex nature of mixed incontinence, which combines features of both stress and urge incontinence, leading to an increased focus on comprehensive and multifaceted treatment approaches.
By end-user, the hospital's segment accounted for the highest revenue-grossing segment in the global urinary incontinence treatment devices market in 2023 owing to the growing number of surgical procedures and interventions for urinary incontinence conducted in hospital settings, the availability of advanced diagnostic facilities, and the preference for comprehensive medical care. For instance, in November 2023, Ethicon US, LLC presented favorable findings from a clinical study on their TVT-SecurTM sling system for treating stress urine incontinence in women. Additionally, the home use segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing trend towards patient-centric care, advancements in user-friendly and portable urinary incontinence treatment devices suitable for home use, and a growing preference for non-invasive and self-managed solutions.
North American region is anticipated to have the highest revenue share during the forecast period owing to the robust healthcare infrastructure, a high prevalence of urinary incontinence, a rapidly aging population, and increased awareness and acceptance of advanced medical technologies. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing healthcare expenditure, rising awareness about urinary incontinence, a growing elderly population, and the expansion of healthcare infrastructure. For instance, Boston Scientific Corporation launched its LynxTM Adjustable Transobturator System, a minimally invasive device for treating stress urine incontinence in women, in August 2023.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Urinary incontinence is a prevalent ailment that affects millions of individuals worldwide, with one in every four women and one in every ten men experiencing it at some time in their lives. The prevalence of urine incontinence rises with age, with more than half of persons over 65 suffering from the disorder. Obesity, neurological problems, and childbirth can all play a role in the development of urine incontinence. For instance, Medtronic plc received FDA clearance for its InterStimTM S9 system, a neurostimulation device for treating overactive bladder syndrome and urine urgency incontinence, in December 2023.
By product, the urethral slings segment accounted for the highest revenue-grossing segment in the global urinary incontinence treatment devices market in 2023 owing to the increasing prevalence of stress urinary incontinence and the effectiveness of urethral slings in providing long-term relief, driving heightened demand for this specific treatment option among healthcare providers and patients alike. For instance, Boston Scientific Corporation announced the successful enrollment of the first patients in a clinical study assessing their IntellisensTM System, a smart drainage catheter with real-time fluid monitoring, in November 2023. Additionally, the electrical stimulation devices segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising adoption of non-invasive and technologically advanced solutions for urinary incontinence management, increased awareness about the effectiveness of electrical stimulation in strengthening pelvic floor muscles, and the growing preference for conservative treatment options.
By incontinence type, the stress urinary incontinence segment accounted for the highest revenue-grossing segment in the global urinary incontinence treatment devices market in 2023 owing to the growing prevalence of stress urinary incontinence, particularly among women, increased awareness and diagnosis rates, and the effectiveness of specialized treatment devices tailored to address the specific needs of individuals with stress urinary incontinence. For instance, Coloplast A/S announced a strategic agreement with Oxford University Hospitals in December 2023 to develop and test novel technologies for the management of urinary incontinence. Additionally, the mixed incontinence segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing recognition of the complex nature of mixed incontinence, which combines features of both stress and urge incontinence, leading to an increased focus on comprehensive and multifaceted treatment approaches.
By end-user, the hospital's segment accounted for the highest revenue-grossing segment in the global urinary incontinence treatment devices market in 2023 owing to the growing number of surgical procedures and interventions for urinary incontinence conducted in hospital settings, the availability of advanced diagnostic facilities, and the preference for comprehensive medical care. For instance, in November 2023, Ethicon US, LLC presented favorable findings from a clinical study on their TVT-SecurTM sling system for treating stress urine incontinence in women. Additionally, the home use segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing trend towards patient-centric care, advancements in user-friendly and portable urinary incontinence treatment devices suitable for home use, and a growing preference for non-invasive and self-managed solutions.
North American region is anticipated to have the highest revenue share during the forecast period owing to the robust healthcare infrastructure, a high prevalence of urinary incontinence, a rapidly aging population, and increased awareness and acceptance of advanced medical technologies. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing healthcare expenditure, rising awareness about urinary incontinence, a growing elderly population, and the expansion of healthcare infrastructure. For instance, Boston Scientific Corporation launched its LynxTM Adjustable Transobturator System, a minimally invasive device for treating stress urine incontinence in women, in August 2023.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Product, Incontinence Type, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
Segmentation: Urinary Incontinence Treatment Devices Market Report 2023 - 2034
Urinary Incontinence Treatment Devices Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Urethral Slings
- Electrical Stimulation Devices
- Artificial Urinary Sphincters
- Catheters
Urinary Incontinence Treatment Devices Market Analysis & Forecast by Incontinence Type 2023 - 2034 (Revenue USD Bn)
- Stress Urinary Incontinence
- Urge Urinary Incontinence
- Mixed Incontinence
- Overflow Incontinence
Urinary Incontinence Treatment Devices Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)
- Hospitals
- Ambulatory Surgery Centers
- Clinics
- Home Use
Urinary Incontinence Treatment Devices Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Urinary Incontinence Treatment Devices Market: Product Estimates & Trend Analysis
8. Urinary Incontinence Treatment Devices Market: Incontinence Type Estimates & Trend Analysis
9. Urinary Incontinence Treatment Devices Market: End-User Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Urinary Incontinence Treatment Devices Market
12. Europe Global Urinary Incontinence Treatment Devices Market
13. Asia Pacific Global Urinary Incontinence Treatment Devices Market
14. Latin America Global Urinary Incontinence Treatment Devices Market
15. MEA Global Urinary Incontinence Treatment Devices Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Roche Diagnostics
- Siemens Healthineers
- Abbott Laboratories
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- Becton
- Dickinson and Company (BD)
- Bio-Rad Laboratories Inc.
- Ortho Clinical Diagnostics
- Sysmex Corporation
- Beckman Coulter Inc. (a subsidiary of Danaher)
- BioMérieux SA
- Qiagen N.V.
- Hologic Inc.
- PerkinElmer Inc.
- Agilent Technologies Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 3.23 Billion |
| Forecasted Market Value ( USD | $ 7.36 Billion |
| Compound Annual Growth Rate | 7.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
